You are here

devices

Medtech regulation outlook in 2023: Faster approvals among priorities as AI moves to fore

Medtech Dive

Fri, 01/27/23 - 10:41 am

device approvals

artificial intelligence

Will 2023 Usher in a New Era for Medtech M&A?

Medical Devices and Diagnostics Industry

Wed, 01/25/23 - 10:46 am

Insulet reports personal-data leak of 29,000 insulin pump customers

Medtech Dive

Wed, 01/25/23 - 10:22 am

Medtech investments hold up despite market turmoil

EP Vantage

Tue, 01/24/23 - 10:17 am

venture capital

Delfi Diagnostics

Enable Injections

Kry International

A year to forget for medtech stocks

EP Vantage

Mon, 01/23/23 - 10:46 am

Boston Scientific

Becton Dickinson

Align Technology

FDA demands additional data on Abbott rival to Medtronic balloon, setting back approval timeline

Medtech Dive

Sun, 01/22/23 - 12:58 pm

drug-coated balloons

Expert: Studies linking recalled 510(k) devices to problematic predicate products are ‘warning shot’ for manufacturers

RAPS.org

Tue, 01/17/23 - 10:53 pm

Medtech approvals stagnate

EP Vantage

Tue, 01/17/23 - 10:21 am

device approvals

‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts

Medtech Dive

Fri, 01/13/23 - 11:08 am

Masimo Takes a Bite Out of Apple

Medical Devices and Diagnostics Industry

Wed, 01/11/23 - 10:50 am

Biogen, scrapping for SMA market share, bets $10M on implant to improve delivery of Spinraza

Fierce Pharma

Tue, 01/10/23 - 10:55 am

Alcyone Therapeutics

What Medical Device Inventor Evaded the Nazis at Age 15?

Medical Devices and Diagnostics Industry

Tue, 01/10/23 - 10:48 am

Michel Mirowski

Medtech in a Minute: Kicking off 2023 with Spinoffs, M&A, and More

Medical Devices and Diagnostics Industry

Mon, 01/9/23 - 10:30 am

Baxter International

Biogen and Alcyone Therapeutics partner up on novel device for neurological ASO therapies

Biopharma Reporter

Thu, 01/5/23 - 04:56 pm

Alcyone Therapeutics

Novocure shares soar on positive lung cancer data

BioPharma Dive

Thu, 01/5/23 - 04:52 pm

clinical trials

‘Mea culpa’: What Goldman Sachs analysts got wrong about Medtronic in 2022

Medtech Dive

Thu, 01/5/23 - 10:02 am

FDA classifies slew of class II devices following de novo procedures

RAPS.org

Wed, 01/4/23 - 05:24 pm

de novo pathway

RAPS.org

Wed, 01/4/23 - 09:28 am

Medtronic starts US robotic surgery trial in push to challenge Intuitive

Medtech Dive

Tue, 12/20/22 - 10:39 am

robotic surgery

clinical trials

Siemens Healthineers, GE HealthCare reportedly express interest in Medtronic units

Mass Device

Fri, 12/16/22 - 10:24 am

Siemens Healthineers

Pages